Active Ingredient History

NOW
  • Now
Iferanserin is a drug which acts as a selective 5-HT2A receptor antagonist. It is under development as an intra-rectal formulation for the treatment of hemorrhoid disease, and as of February 2012, is in phase IIb clinical trials.   Wikipedia

  • SMILES: CN1CCCC[C@H]1CCc2ccccc2NC(=O)\C=C\c3ccccc3
  • InChIKey: UXIPFQUBOVWAQW-UEBLJOKOSA-N
  • Mol. Mass: 348.49
  • ALogP: 4.76
  • ChEMBL Molecules:
More Chemistry
iferanserin | ven-309

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue